If your IVF cycle has failed — whether once, twice, or more times — you have almost certainly sat in a doctor's office and received some version of the same explanation: sometimes embryos just don't implant, the timing wasn't right, your body needs another chance, let's try again with the same protocol.
It sounds reasonable. It is delivered gently. And for many couples, it is accepted — because what else is there to do when the person who is supposed to have the answers tells you that sometimes these things just happen?
But here is the truth that too few fertility doctors communicate clearly: IVF failure is rarely random. In the vast majority of cases, a failed IVF cycle has a specific, identifiable medical reason — a reason that can be investigated, understood, and in most cases addressed before the next attempt.
The problem is that finding that reason requires more diagnostic effort than most clinics are willing or equipped to invest. It is easier — and commercially more straightforward — to recommend another cycle with the same protocol than to spend the time and resources to understand why the last one failed.
At Metro IVF in Ambikapur, Dr. Ashish Soni's entire approach to failed IVF cases is built on a single conviction: every failure has a reason, and finding that reason is the most important thing that can be done before attempting another cycle.
This article identifies the ten most common real medical reasons for IVF failure — the ones that are frequently present, rarely explained, and entirely investigable if the right questions are asked.
Before We Begin: What "IVF Failure" Actually Means
IVF failure can mean different things in different contexts. It can mean that fertilization did not occur — that the eggs and sperm did not combine to form embryos. It can mean that embryos formed but stopped developing before reaching a transferable stage. It can mean that a transfer was performed but the embryo did not implant. Or it can mean that implantation occurred briefly — a positive blood test was obtained — but the pregnancy did not continue and ended in early miscarriage.
Each of these scenarios has a different set of likely causes and requires a different diagnostic approach. The ten reasons explored in this article cover the full spectrum — from fertilization failure to implantation failure to early pregnancy loss — because understanding where in the process the failure is occurring is the essential first step in understanding why.
Reason 1: Sperm DNA Fragmentation — The Most Overlooked Factor in IVF Failure
Of all the reasons IVF fails that are routinely missed by fertility clinics, sperm DNA fragmentation is the most common and the most consequential.
Standard semen analysis measures three parameters: sperm count, motility, and morphology. A man whose count, motility, and morphology are within normal ranges is typically told his sperm is fine — and the focus of investigation shifts entirely to the woman.
But normal semen analysis does not tell you whether the DNA inside the sperm — the genetic material that will become half of the embryo's chromosomes — is intact. Sperm DNA fragmentation refers to breaks and damage in this genetic material. High levels of fragmentation can occur even when all three standard parameters are normal.
The consequences of high sperm DNA fragmentation in IVF are significant. Fertilization may occur normally, and the embryo may develop to a transferable stage — but the DNA damage carried within it compromises the embryo's developmental capacity. Implantation fails, or the pregnancy begins and then stops. The couple is told the cycle failed without being told why. And the next cycle begins with the same sperm — and the same DNA damage — because no one has tested for it.
Testing for sperm DNA fragmentation requires a specific test — the DNA Fragmentation Index (DFI) — that is not part of standard semen analysis and is not performed at many clinics. At Metro IVF, Dr. Soni considers it an essential part of the evaluation for any couple with unexplained IVF failure.
When high sperm DNA fragmentation is identified, it can often be addressed — through antioxidant therapy, through testicular sperm extraction which retrieves sperm before DNA damage accumulates in the epididymis, or through timed sample collection strategies that optimize DNA integrity. But none of these interventions can happen if the problem is never identified.
Reason 2: Poor Egg Quality — And What Actually Causes It
Egg quality is the most commonly cited explanation for IVF failure — and the one that is most often delivered as a dead-end conclusion rather than an investigable finding.
"Your egg quality was poor" is frequently offered as a complete explanation. It is not. It is the beginning of the right question: why was egg quality poor, and is there anything that can be done about it?
Egg quality is affected by age — this is the factor most doctors cite, and it is real. But it is not the only factor. Ovarian stimulation protocols that are too aggressive can cause the follicles to develop too rapidly, producing eggs that have not matured properly. Stimulation that is too mild produces too few eggs to work with. Timing the trigger injection incorrectly — too early or too late — results in eggs that are either immature or already degrading at the time of retrieval.
Beyond stimulation factors, conditions like endometriosis directly compromise egg quality through inflammatory mechanisms in the ovarian environment. Thyroid dysfunction, when untreated or inadequately treated, impairs follicle development. Nutritional deficiencies — particularly in CoQ10, vitamin D, and folate — have a measurable impact on mitochondrial function within eggs, which is central to egg quality.
Understanding which of these factors — or which combination of them — is contributing to poor egg quality in a specific patient requires the kind of investigative thinking that a one-protocol-fits-all clinic does not apply. But it is the thinking that separates a cycle that fails again from one that succeeds.
Reason 3: Thin or Unreceptive Endometrium — The Implantation Environment
An embryo, however perfect, cannot implant in a uterine lining that is inadequately prepared to receive it. The endometrium — the inner lining of the uterus — must reach a specific thickness, typically at least 7 to 8 millimetres, and must undergo a specific pattern of maturation before it is receptive to an embryo.
Thin endometrium is a well-recognized cause of implantation failure. It can result from previous uterine surgeries, from scarring caused by infections, from inadequate estrogen stimulation, or from poor blood flow to the uterine lining. In some women, the lining does not respond to standard estrogen supplementation and remains persistently thin despite multiple attempts.
But thickness alone is not sufficient. Even a lining that appears adequate on ultrasound may not be functionally receptive to an embryo if the window of implantation — the specific window of days during which the endometrium can accept an embryo — does not align with the timing of the transfer.
This misalignment is addressed by a test called ERA — Endometrial Receptivity Analysis — which examines the gene expression pattern of the endometrial tissue to determine the precise timing of the implantation window for that individual woman. In some women, the window is shifted by one or two days from the standard assumed timing, and embryo transfers timed to the standard protocol consistently miss it. ERA identifies the correct timing and allows transfers to be scheduled accordingly.
ERA testing is not recommended for every patient — but for women with repeated implantation failure despite good embryos and an apparently adequate lining, it is one of the most diagnostically valuable tests available.
Reason 4: Chromosomal Abnormalities in the Embryo
Even when stimulation is good, fertilization is successful, and embryos develop to blastocyst stage, a proportion of those embryos will carry chromosomal abnormalities — errors in the number or structure of chromosomes — that make them incompatible with sustained pregnancy. When such an embryo is transferred, implantation may not occur, or it may occur briefly before the pregnancy ends in early miscarriage.
Chromosomal abnormalities in embryos become more frequent with advancing maternal age — this is the primary biological mechanism behind the well-documented age-related decline in IVF success rates. But they can occur at any age, and in some couples, the rate of chromosomally abnormal embryos is higher than expected.
Preimplantation Genetic Testing for Aneuploidies — PGT-A — is a laboratory technique that allows embryos to be screened for chromosomal abnormalities before transfer. Only euploid embryos — those with the correct number of chromosomes — are selected for transfer. This screening significantly improves the implantation rate and reduces the risk of miscarriage, because transfers of chromosomally abnormal embryos are avoided.
PGT-A is not indicated for every couple. But for women over 37, for couples with recurrent miscarriage, or for those who have experienced repeated implantation failure with good-quality embryos, it is a diagnostically and therapeutically valuable tool that many clinics never discuss.
Reason 5: Uterine Structural Abnormalities — The Cavity That Was Never Checked
A structurally abnormal uterine cavity can prevent implantation even when embryo quality and endometrial thickness are both adequate. The most common uterine abnormalities that interfere with implantation include endometrial polyps, submucosal fibroids, intrauterine adhesions (scar tissue), and uterine septum — a band of tissue that divides the uterine cavity partially or completely.
Each of these conditions can be present without causing significant symptoms. A woman may have a polyp or a septum and have no idea — because these conditions are not reliably detected on a standard pelvic ultrasound. They require specific visualization through hysteroscopy — a procedure in which a thin camera is passed into the uterine cavity — to be reliably identified.
At many fertility clinics, hysteroscopy before an IVF cycle is not routine. It is performed after failure, if at all. This means that some couples go through one or more complete IVF cycles with a structural barrier to implantation in the uterine cavity — a barrier that could have been identified and corrected before the first attempt.
At Metro IVF, Dr. Soni's protocol includes uterine cavity assessment as a routine part of the pre-treatment evaluation. If a cavity abnormality is found, it is corrected before the IVF cycle begins — not discovered after a cycle has already failed.
Reason 6: Immunological Factors — When the Body Fights the Embryo
The immune system plays a role in implantation that is complex, incompletely understood, and chronically under-investigated in routine IVF practice.
For a pregnancy to establish, the immune system must tolerate the embryo — which carries genetic material from the father and is therefore, immunologically speaking, partially foreign. In most women, this tolerance is established naturally. In some, it is not — and the immune system mounts a response that prevents or disrupts implantation.
Several immunological conditions have been associated with implantation failure and recurrent pregnancy loss. Antiphospholipid syndrome — a condition in which the immune system produces antibodies that increase blood clotting — can prevent the development of the placental blood supply necessary for pregnancy to continue. Natural killer cell abnormalities — either elevated uterine NK cell activity or abnormal NK cell function — have been associated with repeated implantation failure in some studies. Thyroid antibodies, even in women with normal thyroid function, have been linked to higher rates of implantation failure and miscarriage.
Immunological testing is not standard in routine IVF work-ups at most clinics. It is more commonly performed in specialist centers with a specific interest in difficult cases. At Metro IVF, immunological evaluation is considered in any couple where repeated implantation failure has occurred without a clear structural, embryological, or hormonal explanation.
Reason 7: Incorrect or Poorly Timed Stimulation Protocol
The ovarian stimulation protocol — the specific combination of medications, doses, and timing used to develop multiple follicles — has a profound effect on egg quality and quantity. A protocol that is right for one patient can be completely wrong for another.
Women with high ovarian reserve — particularly those with PCOS — are at risk of over-stimulation with standard protocols, which can produce many follicles but poor-quality eggs, and can trigger ovarian hyperstimulation syndrome (OHSS) that requires cancellation of the fresh transfer. Women with low ovarian reserve may be under-stimulated with standard doses, producing too few eggs to give a reasonable chance of obtaining viable embryos.
The key word in both scenarios is "standard." Clinics that apply the same protocol — the same starting dose, the same medication, the same monitoring intervals — to every patient are not individualizing treatment to each patient's biology. They are applying an average to individuals — which means that patients who fall significantly above or below the average receive a protocol that is not appropriate for them.
At Metro IVF, every stimulation protocol is designed from the patient's own hormonal parameters — her AMH, her antral follicle count, her age, her body weight, and if available, her response pattern from any previous stimulation cycles. Protocols are adjusted in real time based on monitoring findings. This individualization is not a luxury — it is the clinical standard that every patient deserves, and in complex cases it is the factor that most directly determines whether the cycle produces viable embryos.
Reason 8: Laboratory Quality — The Factor Patients Never See
IVF success depends not just on the doctor in the consultation room but on the embryologist in the laboratory — and on the quality of the environment in which embryos spend their first critical days of development.
Laboratory factors that affect embryo quality and survival include the type and quality of incubators used, the atmospheric conditions maintained within them, the culture media in which embryos develop, the skill and training of the embryology team, and the quality control protocols in place to prevent contamination or temperature fluctuation.
Small failures in laboratory quality have large consequences for embryo development. An incubator that fluctuates in temperature or atmospheric composition by even small margins can compromise embryo development at a cellular level. A culture medium that is not optimally formulated for human embryo development will produce embryos that appear normal under the microscope but have reduced implantation potential.
These factors are invisible to patients — they cannot be assessed from the waiting room or the consultation room. But they are among the most consequential determinants of IVF success. When evaluating a new fertility clinic after a failed cycle elsewhere, asking specifically about laboratory standards — the type of incubators, the quality of culture media, the qualifications of the embryology team, and the accreditation of the laboratory — is not a trivial question. It is one of the most important questions a patient can ask.
Reason 9: Hydrosalpinx — The Blocked Tube That Poisons the Uterus
Hydrosalpinx is a condition in which a blocked fallopian tube fills with fluid. This fluid accumulation does not merely represent a mechanical obstruction to natural conception — which would be the expected concern. In the context of IVF, hydrosalpinx creates an additional and less obvious problem.
The fluid that accumulates in a hydrosalpinx is toxic to embryos. In some women, this fluid periodically drains back into the uterine cavity — and when it does, it creates a uterine environment that is hostile to implantation. Embryo transfers performed into a uterus that is intermittently exposed to hydrosalpinx fluid have significantly lower implantation rates than transfers performed after the hydrosalpinx has been surgically addressed.
The intervention — typically a laparoscopic procedure to remove or clip the affected tube — removes the toxic fluid source and restores the uterine environment. Studies consistently show that IVF success rates in women with hydrosalpinx improve significantly after surgical correction.
Hydrosalpinx can be identified on a carefully performed ultrasound or confirmed through hysterosalpingography (HSG). It is a diagnosable and correctable condition. Yet in clinics that do not routinely screen for it before IVF, it can remain present through multiple failed cycles — silently undermining each one.
Reason 10: Undiagnosed or Undertreated Medical Conditions
Finally — and perhaps most broadly — IVF failure is frequently associated with systemic medical conditions that have either not been diagnosed or have not been adequately treated before treatment begins.
Thyroid dysfunction is the most common of these. Both hypothyroidism and hyperthyroidism, even in subclinical forms, affect egg quality, endometrial receptivity, and early embryo development. The standard TSH threshold considered acceptable for general health — below 4.5 or 5.0 mIU/L in many laboratories — is not the appropriate threshold for IVF patients, where TSH ideally should be below 2.5 mIU/L. A woman whose TSH is 3.8 may be told by her general physician that her thyroid is normal — but in the context of an IVF cycle, it may need to be better controlled.
Uncontrolled or poorly controlled diabetes affects egg quality and endometrial receptivity. Vitamin D deficiency — extraordinarily common in India, including in Chhattisgarh — has been associated with lower IVF success rates in multiple studies. Elevated prolactin, even mildly, can interfere with the luteal phase support that sustains an early pregnancy. Autoimmune conditions, when unrecognized, can create a systemic environment hostile to implantation.
Before every IVF cycle at Metro IVF, Dr. Soni reviews the complete medical picture — not just the fertility parameters, but the overall health status of both partners. Because IVF does not happen in a vacuum, and a cycle that is technically well executed can still fail if the systemic environment is not right.
What to Do If Your IVF Has Failed
If you have been through a failed IVF cycle and received an explanation that felt incomplete, that is because it probably was incomplete.
The right response to a failed cycle is not simply to try again with the same protocol and hope for a different result. The right response is to investigate — to ask the questions that identify which of the reasons described in this article apply to your case, and to make the changes that address those specific causes before the next attempt.
At Metro IVF in Ambikapur, this investigation is what Dr. Ashish Soni does for every patient who comes to him after a failed cycle elsewhere. He reads every previous report. He identifies what was tested and what was not. He runs the tests that have not been done. He asks the questions that have not been asked. And he builds a new protocol based on what he actually finds — not on what was assumed the first time around.
Couples who have failed IVF two, three, four, and five times at other clinics have conceived at Metro IVF — not because of luck, but because the real reason for their failure was finally identified and addressed.
If your IVF has failed and you have not received a satisfying explanation, you deserve one. And finding that explanation — the real one — may be the single most important thing you do before your next cycle.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
Failed IVF? Book a second opinion consultation with Dr. Soni. Find out what was missed — before you try again.